Premium
In vitro biocompatibility of hydroxyapatite‐reinforced polymeric composites manufactured by selective laser sintering
Author(s) -
Zhang Y.,
Hao L.,
Savalani M. M.,
Harris R. A.,
Di Silvio L.,
Tanner K. E.
Publication year - 2008
Publication title -
journal of biomedical materials research part a
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.849
H-Index - 150
eISSN - 1552-4965
pISSN - 1549-3296
DOI - 10.1002/jbm.a.32298
Subject(s) - materials science , biocompatibility , osteoblast , selective laser sintering , alkaline phosphatase , composite material , biomedical engineering , osteocalcin , viability assay , in vitro , sintering , chemistry , medicine , biochemistry , metallurgy , enzyme
The selective laser sintering (SLS) technique was used to manufacture hydroxyapatite‐reinforced polyethylene and polyamide composites as potential customized maxillofacial implants. In vitro tests were carried out to assess cellular responses, in terms of cell attachment, morphology, proliferation, differentiation, and mineralized nodule formation, using primary human osteoblast cells. This study showed that the SLS composite processed was biocompatible, with no adverse effects observed on cell viability and metabolic activity, supporting a normal metabolism and growth pattern for osteoblasts. Positive von Kossa staining demonstrated the presence of bone‐like mineral on the SLS materials. Higher hydroxyapatite content composites enhanced cell proliferation, increased alkaline phosphatase activity, and produced more osteocalcin. The present findings showed that SLS materials have good in vitro biocompatibility and hence demonstrated biologically the potential of SLS for medical applications. © 2008 Wiley Periodicals, Inc. J Biomed Mater Res, 2009